APA Alıntı

Kawano, N., Yoshida, N., Kawano, S., Arakawa, F., Miyoshi, H., Yamada, K., . . . Ohshima, K. (2019). Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018). Intern Med.

Chicago Stili Alıntı

Kawano, Noriaki, et al. "Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients With Aggressive Adult T-cell Leukemia-lymphoma Treated With a Humanized CCR4 Antibody (Mogamulizumab) At a Single Institution During a 6-year Period (2012-2018)." Intern Med 2019.

MLA Alıntı

Kawano, Noriaki, et al. "Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients With Aggressive Adult T-cell Leukemia-lymphoma Treated With a Humanized CCR4 Antibody (Mogamulizumab) At a Single Institution During a 6-year Period (2012-2018)." Intern Med 2019.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..